Effect of safranal on extracellular hippocampal levels of glutamate and aspartate during kainic acid treatment in anesthetized rats

Planta Medica

Volumn 74, Issue 12, 2008, Pages 1441-1445

  Hosseinzadeh, Hossein ^a   Sadeghnia, Hamid R ^b   Rahimi, Athena ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Crocus sativus; Diazepam (DZP); Iridaceae; Kainic acid (KA); Saffron; Safranal

Indexed keywords

ASPARTIC ACID; CROCUS SATIVUS EXTRACT; DIAZEPAM; GLUTAMIC ACID; KAINIC ACID; SAFRANAL; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; MALE; NONHUMAN; RAT; WISTAR RAT;

ANESTHESIA; ANIMALS; ASPARTIC ACID; CYCLOHEXENES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; HIPPOCAMPUS; KAINIC ACID; MALE; RATS; RATS, WISTAR; TERPENES;

CROCUS SATIVUS; IRIDACEAE; RATTUS;

EID: 54249101071     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081335     Document Type: Article

References (25)

1. Abdullaev FI, Espinosa-Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004; 28: 426-32.
2. Hosseinzadeh H, Khosravan V. Anticonvulsant effects of aqueous and ethanolic extracts of Crocus sativus L. stigmas in mice. Arch Iran Med 2002; 5: 44-7
3. Hosseinzadeh H, Talebzadeh F. Anticonvulsant evaluation of safranal and crocinfrom Crocus sativus in mice. Fitoterapia 2005; 76: 722-4
4. Hosseinzadeh H, Sadeghnia HR. Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. J Pharm Pharm Sci 2005; 8: 394-9
5. Hosseinzadeh H, Sadeghnia HR. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: Involvement of GABAergic and opioids systems. Phytomedicine 2007; 14: 256-62
6. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press; 1998
7. Lindroth P, Mopper K. High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde. Anal Chem 1979; 51: 1667-74
8. Takeda A, Tamano H, Oku N. Involvement of unusual glutamate release in kainite-induced seizures in zinc-deficient adult rats. Epilepsy Res 2005; 66: 137-43
9. Ferkany JW, Zaczek R, Coyle JT. Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature 1982; 298: 757-9
10. Takeda A, Hirate JW, Tamano H, Oku N. Zinc movement in the brain under kainite-induced seizures. Epilepsy Res 2003; 54: 123-29
11. Bruhn T, Christensen T, Diemer NH. Evidence for increased cellular uptake of glutamate and aspartate in the rat hippocampus during kainic acid seizures. A microdialysis study using the indicator diffusion method. Epilepsy Res 1997; 26: 363-71
12. Lehmann A, Hagberg H, Jacobson I, Hamberger A. Effects of status epilepticus on extracellular amino acids in the hippocampus. Brain Res 1985; 359: 147-51
13. Chapman AG, Westerberg E, Premachandra M, Meldrum BS. Changes in regional neurotransmitter amino acid levels in rat brain during seizures induced by 1-allylglycine, bicuculline, and kainic acid. J Neurochem 1984; 43: 62-70
14. Nicoletti F, Perciavalle V, Berretta S, Speciale C, Polizzi MC, Patti F et al. Altered time course of changes in the hippocampal concentration of excitatory and inhibitory amino acids during kainate-induced epilepsy. Eur J Pharmacol 1984; 103: 133-7
15. Ferkany JW, Coyle JT. Kainic acid selectively stimulates the release of endogenous excitatory acidic amino acids. J Pharmacol Exp Ther 1983; 225: 399-406
16. Rigaud-Monnet AS, Heron A, Seylaz J, Pinard E. Effect of inhibiting NO synthesis on hippocampal extracellular glutamate concentration in seizures induced by kainic acid. Brain Res 1995; 673: 297-303
17. Ueda Y, Doi T, Tokumaru J, Yokoyama H, Nakajima A, Mitsuyama Y et al. Collapse of extracellular glutamate regulation during epileptogenesis: down-regulation and functional failure of glutamate transporter function in rats with chronic seizures induced by kainic acid. J Neurochem 2001; 76: 892-900
18. Ben-Ari Y, Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci 2000; 23: 580-7
19. Huettner JE. Kainate receptors and synaptic transmission. Prog Neurobiol 2003; 70: 387-407
20. Pinheiro P, Mulle C. Kainate receptors. Cell Tissue Res 2006; 326: 457-82
21. Stafstrom CE, Tandon P, Hori A, Liu Z, Mikati MA, Holmes GL. Acute effects of MK801 on kainic acid-induced seizures in neonatal rats. Epilepsy Res 1997; 26: 335-44
22. Wang Q, Yu S, Simonyi A, Sun GY, Sun AY. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol Neurobiol 2005; 31: 3-16
23. Kanakis CD, Tarantilis PA, Tajmir-Riahi HA, Polissiou MG. Crocetin, dimethylcrocetin, and safranal bind human serum albumin: stability and antioxidative properties. J Agric Food Chem 2007; 55: 970-7
24. Rowley HL, Martin KF, Marsden CA. Decreased GABA release following tonic-clonic seizures is associated with an increase in extracellular glutamate in rat hippocampus in vivo. Neurosci 1995; 68: 415-22
25. De Bonnel G, De Montigny C. Benzodiazepines selectively antagonize kainate-induced activation in the rat hippocampus. Eur J Pharmacol 1983; 93: 45-54